Immune determinants of COVID-19 disease presentation and severity

被引:0
|
作者
Petter Brodin
机构
[1] Karolinska Institutet,Science for Life Laboratory, Department. of Women’s and Children’s Health
[2] Karolinska University Hospital,Pediatric Rheumatology
来源
Nature Medicine | 2021年 / 27卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
COVID-19, caused by SARS-CoV-2 infection, is mild to moderate in the majority of previously healthy individuals, but can cause life-threatening disease or persistent debilitating symptoms in some cases. The most important determinant of disease severity is age, with individuals over 65 years having the greatest risk of requiring intensive care, and men are more susceptible than women. In contrast to other respiratory viral infections, young children seem to be less severely affected. It is now clear that mild to severe acute infection is not the only outcome of COVID-19, and long-lasting symptoms are also possible. In contrast to severe acute COVID-19, such ‘long COVID’ is seemingly more likely in women than in men. Also, postinfectious hyperinflammatory disease has been described as an additional outcome after SARS-CoV-2 infection. Here I discuss our current understanding of the immunological determinants of COVID-19 disease presentation and severity and relate this to known immune-system differences between young and old people and between men and women, and other factors associated with different disease presentations and severity.
引用
收藏
页码:28 / 33
页数:5
相关论文
共 50 条
  • [41] Identification of genetic determinants of COVID-19 severity by exome sequencing
    Cappadona, Claudio
    Rimoldi, Valeria
    Bottaro, Sandro
    Cardamone, Giulia
    Paraboschi, Elvezia Maria
    Asselta, Rosanna
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 707 - 708
  • [42] Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity
    Eric S. Geanes
    Rebecca McLennan
    Cas LeMaster
    Todd Bradley
    Communications Medicine, 4
  • [43] Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity
    Geanes, Eric S.
    Mclennan, Rebecca
    Lemaster, Cas
    Bradley, Todd
    COMMUNICATIONS MEDICINE, 2024, 4 (01):
  • [44] Differentially expressed immune response genes in COVID-19 patients based on disease severity
    Li, Shasha
    Duan, Xiaoqiong
    Li, Yujia
    Li, Ming
    Gao, Yong
    Li, Tuantuan
    Li, Shilin
    Tan, Lin
    Shao, Tuo
    Jeyarajan, Andre J.
    Chen, Limin
    Han, Mingfeng
    Lin, Wenyu
    Li, Xiuyong
    AGING-US, 2021, 13 (07): : 9265 - 9276
  • [45] Gut microbiota composition is associated with disease severity and host immune responses in COVID-19
    Fan, Ruyue
    Liu, Shuai
    Sun, Na
    Yang, Ying
    Deng, Xia
    Hu, Bin
    Sun, Changhua
    Wen, Chengli
    Li, Hui
    Cheng, Dong
    Huang, Chuanjun
    Hou, Peibin
    Zhang, Tianliang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [46] COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation
    Lee, Abby C.
    Castaneda, Grant
    Li, Wei Tse
    Chen, Chengyu
    Shende, Neil
    Chakladar, Jaideep
    Taub, Pam R.
    Chang, Eric Y.
    Ongkeko, Weg M.
    VIRUSES-BASEL, 2021, 13 (06):
  • [47] Vitamin D and disease severity in coronavirus disease 19 (COVID-19)
    Adami, G.
    Giollo, A.
    Fassio, A.
    Benini, C.
    Bertoldo, E.
    Bertoldo, F.
    Orsolini, G.
    Idolazzi, L.
    Viapiana, O.
    Giannini, S.
    Passeri, G.
    Tacconelli, E.
    Micheletto, C.
    Gatti, D.
    Rossini, M.
    REUMATISMO, 2020, 72 (04) : 189 - 196
  • [48] COVID-19 disease severity and mortality determinants: A large population-based analysis in Oman
    Al Wahaibi, Adil
    Al Rawahi, Bader
    Patel, Prakash Kurubarahalli
    Al Khalili, Sulien
    Al Maani, Amal
    Al-Abri, Seif
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2021, 39
  • [49] Severity of COVID-19 Infectious and Immune-Based Profile
    Shahi, Heshmat
    Kiaee, Fatemeh
    Marjani, Majid
    Mortaz, Esmaeil
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2024, 17 (01)
  • [50] Editorial: Definition of the immune parameters related to COVID-19 severity
    Tincati, Camilla
    de Vries, Rory
    Jesenak, Milos
    Marchetti, Giulia
    FRONTIERS IN IMMUNOLOGY, 2023, 14